Source:http://linkedlifedata.com/resource/pubmed/id/11703656
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-11-12
|
pubmed:abstractText |
Arylamine N-acetyltransferases (NATs; E.C 2.3.1.5) N-acetylate arylhydralazine and arylamine substrates using acetyl coenzyme A. Human NAT2 acetylates and inactivates the antituberculosis drug, isoniazid (INH), and is polymorphic. We previously demonstrated that there is a homologue of human NAT2 in Mycobacterium tuberculosis, whose product N-acetylates INH in vitro. We now demonstrate that the nat gene is expressed in M. tuberculosis and M. bovis Bacille Calmette-Guerin (BCG), using reverse transcription-polymerase chain reaction and Western blotting. The NAT protein is active in M. bovis BCG in vivo, as detected by the presence of N-acetyl INH in M. bovis BCG lysates grown in INH. Sequence analysis of the M. tuberculosis nat coding region reveals a single nucleotide polymorphism in 18% of a random cohort of M. tuberculosis clinical isolates, conferring a G to R change. The recombinant mutant protein appears less stable than the wild type, and has an apparent affinity for INH of 10-fold less than the wild type. Modelling the change in M. tuberculosis NAT shows that the G to R change is close to the active site, and supports the experimental findings. Minimum inhibitory concentration data suggest that this polymorphism in nat is linked to low-level changes in the INH susceptibility of M. tuberculosis clinical isolates.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arylamine N-Acetyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid,
http://linkedlifedata.com/resource/pubmed/chemical/NAT2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0950-382X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
309-17
|
pubmed:dateRevised |
2010-9-8
|
pubmed:meshHeading |
pubmed-meshheading:11703656-Acetylation,
pubmed-meshheading:11703656-Arylamine N-Acetyltransferase,
pubmed-meshheading:11703656-Blotting, Western,
pubmed-meshheading:11703656-Humans,
pubmed-meshheading:11703656-Isoniazid,
pubmed-meshheading:11703656-Microbial Sensitivity Tests,
pubmed-meshheading:11703656-Models, Molecular,
pubmed-meshheading:11703656-Mycobacterium bovis,
pubmed-meshheading:11703656-Mycobacterium tuberculosis,
pubmed-meshheading:11703656-Phylogeny,
pubmed-meshheading:11703656-Polymorphism, Genetic,
pubmed-meshheading:11703656-Protein Conformation,
pubmed-meshheading:11703656-RNA, Messenger,
pubmed-meshheading:11703656-Recombinant Proteins,
pubmed-meshheading:11703656-Reverse Transcriptase Polymerase Chain Reaction
|
pubmed:year |
2001
|
pubmed:articleTitle |
Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
|
pubmed:affiliation |
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK. anna.upton@pharm.ox.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|